An Eye-Opening Experience Through a Metastatic Melanoma Journey
June 18, 2021Guest blog from Kyle Lewis, a stage IV metastatic melanoma survivor: Clank. Clank. Clank thud. Whoosh. Dang – my range is off. Clank. Whoosh. Whoosh. Ouch. I better get out of here before somebody sees me. It was November 2019 and I was out shooting …
Funding Opportunities for the FY21 Melanoma Research Program Open for Applications
May 14, 2021May 14, 2021 – The MRF is pleased to announce that the Congressionally Directed Medical Research Program’s Melanoma Research Program is now accepting pre-applications for the following awards – Idea Award, Melanoma Academy Leadership Award, Melanoma Ac …
Leading Skin Cancer Organizations Urge the FDA to Ban Tanning Beds for Minors
March 12, 2021WASHINGTON, DC – The Melanoma Research Foundation (MRF) recently signed- on to a letter from the National Council of Skin Cancer Prevention (NCSCP) urging the U.S. Food and Drug Administration (FDA) to finalize the proposed rules entitled General and P …
FDA Grants Alkermes Orphan Drug Designation for the Treatment of Mucosal Melanoma
March 11, 2021WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has recently granted orphan drug designation for the treatment of mucosal melanoma to Alkermes’ investigational engineered interleukin-2 (IL-2) variant immunotherapy, nemvaleukin alfa (“nemva …
130 Organizations Call to the President to Prioritize Cancer Patients and Survivors for COVID-19 Vaccine
February 19, 2021WASHINGTON, DC – As concerns rise about the limited number of COVID-19 vaccines across the U.S., the Melanoma Research Foundation joined the American Association for Cancer Research (AACR) on a letter to President Joseph R. Biden, key members of his ad …
Recent Comments